Plain-English translation of NCT04442789 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is examining what happens to people's health months and years after they were hospitalized with severe COVID-19. Researchers want to understand which patients develop lasting problems in their lungs, heart, kidneys, and other organs, and how common these problems are. By carefully monitoring patients over time, the study aims to identify which people need ongoing medical care and support.
We know that severe COVID-19 can damage multiple organs during the acute illness, but we don't yet understand which patients will have lasting problems after they recover and go home. This study exists to answer that critical question so doctors can better help and monitor people who have had severe COVID-19.
You likely qualify if…
You likely don't qualify if…
As a participant, you would undergo clinical examinations and monitoring of your lung function and other organ health. The study will track your recovery over time to see if you develop any long-term effects from your severe COVID-19 infection. The exact schedule and number of visits will be determined by the research team, but the goal is to monitor your health in the months and years after your hospitalization.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Germany
Enrollment target
~120 participants
Started
May 2020
Primary completion
July 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ulrich Matt, MD, PhD
University of Giessen
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.